Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Scott A. Celinski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3436-4641; OpenAlex author ID A5060815654. Sources: ClinicalTrials.gov.

Their work

Papers
4
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2012: 1 trial · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 4

  1. Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41591-026-04625-x↗
  2. Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Co-author DOI 10.1038/s41591-026-04775-y↗
  3. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Co-author DOI 10.1053/j.gastro.2022.06.090↗
  4. Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer. Co-author DOI 10.4240/wjgs.v9.i4.103↗

Trials 1

  1. Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer Principal investigator NCT01771146↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John S. Bolton · 3 shared papers, 2022–2026 · strength 0.50
  2. Derek Cridebring · 3 shared papers, 2022–2026 · strength 0.50
  3. Eunsung Jun · 3 shared papers, 2022–2026 · strength 0.50
  4. Carlos Roberto Becerra · 3 shared papers, 2022–2026 · strength 0.50
  5. Haiyong Han · 3 shared papers, 2022–2026 · strength 0.50
  6. Joon Oh Park · 3 shared papers, 2022–2026 · strength 0.50
  7. Erkut Hasan Borazanci · 3 shared papers, 2022–2026 · strength 0.50
  8. Ajay Goel · 3 shared papers, 2022–2026 · strength 0.50
  9. Daniel D. Von Hoff · 3 shared papers, 2022–2026 · strength 0.50
  10. Caiming Xu · 2 shared papers, 2026 · strength 0.39
  11. Mitsuro Kanda · 2 shared papers, 2026 · strength 0.39
  12. Laleh Golkar Melstrom · 2 shared papers, 2026 · strength 0.39
  13. Giulia Martina Cavestro · 2 shared papers, 2026 · strength 0.39
  14. Douglas B. Evans · 2 shared papers, 2026 · strength 0.39
  15. David L. Bartlett · 2 shared papers, 2026 · strength 0.39
  16. Vincent M. Chung · 2 shared papers, 2026 · strength 0.39
  17. Alessandro Mannucci · 2 shared papers, 2026 · strength 0.39
  18. Song Cheol Kim · 2 shared papers, 2026 · strength 0.39
  19. Dong Shang · 2 shared papers, 2026 · strength 0.39
  20. Mustafa Raoof · 2 shared papers, 2026 · strength 0.39
  21. Guixin Zhang · 1 shared paper, 2026 · strength 0.20
  22. Kota Nakamura · 1 shared paper, 2022 · strength 0.11
  23. In Woong Han · 1 shared paper, 2022 · strength 0.11
  24. Suguru Yamada · 1 shared paper, 2022 · strength 0.11
  25. Satoshi Nishiwada · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.